Algipharma AS
- Country
- 🇳🇴Norway
- Ownership
- Private
- Established
- 2006-08-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.algipharma.com
Clinical Trials
17
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients with Cystic Fibrosis
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: OligoG DPI
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- AlgiPharma AS
- Target Recruit Count
- 15
- Registration Number
- NCT03822455
- Locations
- 🇦🇺
John Hunter Hospital, Newcastle, New South Wales, Australia
A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: OligoG Dry powder for inhalation
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2022-06-30
- Lead Sponsor
- AlgiPharma AS
- Registration Number
- NCT03698448
- Locations
- 🇩🇪
CF Zentrum Köln, Universitätskrankenhaus Köln, Cologne, Germany
A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection
- Conditions
- Burkholderia InfectionCystic Fibrosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-05-27
- Last Posted Date
- 2018-04-19
- Lead Sponsor
- AlgiPharma AS
- Target Recruit Count
- 15
- Registration Number
- NCT02453789
- Locations
- 🇩🇪
Pneumologische Praxis Pasing, Münich, Münich-Pasing, Germany
🇩🇪Charité Universitätsmedizin Berlin, Berlin, Germany
A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis
- First Posted Date
- 2014-06-06
- Last Posted Date
- 2018-04-19
- Lead Sponsor
- AlgiPharma AS
- Target Recruit Count
- 65
- Registration Number
- NCT02157922
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
🇩🇪Pediatric Pulmonology and Immunology, Charité Universitätsmedizin, Berlin, Germany
🇩🇪CF Zentrum Köln, Universitätskrankenhaus Köln, Cologne, Germany
A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis
- First Posted Date
- 2011-11-04
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- AlgiPharma AS
- Target Recruit Count
- 26
- Registration Number
- NCT01465529
- Locations
- 🇮🇪
Beaumont Hospital, Dublin, Ireland
🇮🇪University College Hospital Galway, Galway, Ireland
🇬🇧Liverpool Heart & Chest Hospital, Liverpool, United Kingdom
- Prev
- 1
- 2
- Next